You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

~ Buy the OPZELURA (ruxolitinib phosphate) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Price Trends for OPZELURA


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for OPZELURA

Average Pharmacy Cost for OPZELURA

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
OPZELURA 1.5% CREAM 50881-0007-05 32.82960 GM 2024-11-20
OPZELURA 1.5% CREAM 50881-0007-05 32.84371 GM 2024-10-23
OPZELURA 1.5% CREAM 50881-0007-05 32.85798 GM 2024-09-18
OPZELURA 1.5% CREAM 50881-0007-05 32.87175 GM 2024-08-21
OPZELURA 1.5% CREAM 50881-0007-05 32.87012 GM 2024-07-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for OPZELURA

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
OPZELURA 1.5% CREAM Incyte Corporation 50881-0007-05 60GM 1959.80 32.66333 GM 2023-01-01 - 2025-08-14 FSS
OPZELURA 1.5% CREAM Incyte Corporation 50881-0007-05 60GM 1421.36 23.68933 GM 2024-01-01 - 2025-08-14 Big4
OPZELURA 1.5% CREAM Incyte Corporation 50881-0007-05 60GM 1439.35 23.98917 GM 2022-04-15 - 2025-08-14 Big4
OPZELURA 1.5% CREAM Incyte Corporation 50881-0007-05 60GM 2018.01 33.63350 GM 2024-01-01 - 2025-08-14 FSS
OPZELURA 1.5% CREAM Incyte Corporation 50881-0007-05 60GM 1959.80 32.66333 GM 2022-04-15 - 2025-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.